Your browser is no longer supported. Please, upgrade your browser.
Settings
SLNO [NASD]
Soleno Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own2.30% Shs Outstand79.73M Perf Week-4.84%
Market Cap96.45M Forward P/E- EPS next Y-0.29 Insider Trans-0.13% Shs Float66.60M Perf Month-28.05%
Income-24.60M PEG- EPS next Q-0.08 Inst Own58.60% Short Float2.60% Perf Quarter-45.37%
Sales- P/S- EPS this Y56.30% Inst Trans1.20% Short Ratio0.89 Perf Half Y-40.10%
Book/sh0.57 P/B2.07 EPS next Y6.50% ROA-39.80% Target Price- Perf Year-61.81%
Cash/sh- P/C- EPS next 5Y15.00% ROE-61.90% 52W Range1.11 - 4.39 Perf YTD-38.86%
Dividend- P/FCF- EPS past 5Y45.80% ROI- 52W High-73.92% Beta0.44
Dividend %- Quick Ratio5.80 Sales past 5Y- Gross Margin- 52W Low3.14% ATR0.11
Employees17 Current Ratio5.80 Sales Q/Q- Oper. Margin- RSI (14)33.68 Volatility7.55% 7.60%
OptionableYes Debt/Eq0.00 EPS Q/Q89.90% Profit Margin- Rel Volume0.79 Prev Close1.18
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.95M Price1.14
Recom1.30 SMA20-11.45% SMA50-42.22% SMA200-41.76% Volume381,916 Change-2.97%
Sep-29-20Initiated Guggenheim Buy $8
Jan-10-20Initiated Craig Hallum Buy $8
Dec-23-19Initiated Oppenheimer Outperform $10
Feb-13-18Reiterated Maxim Group Buy $8 → $4
Apr-14-21 08:40PM  
Mar-30-21 07:02AM  
Mar-29-21 10:05AM  
Mar-09-21 04:01PM  
11:00AM  
06:40AM  
Mar-08-21 08:53AM  
08:00AM  
06:35AM  
Mar-03-21 04:01PM  
Feb-23-21 09:38AM  
Feb-05-21 08:00AM  
Jan-28-21 08:00AM  
Jan-04-21 08:00AM  
Dec-28-20 08:43AM  
Dec-13-20 09:44PM  
Dec-11-20 08:30AM  
Nov-10-20 04:01PM  
Nov-03-20 04:01PM  
Oct-29-20 12:06PM  
Oct-02-20 10:46AM  
Sep-30-20 02:40PM  
Sep-15-20 08:00AM  
Aug-20-20 08:35AM  
Aug-10-20 04:01PM  
Jul-27-20 10:09AM  
Jun-29-20 09:07AM  
09:02AM  
08:00AM  
Jun-26-20 04:01PM  
Jun-25-20 11:15PM  
04:03PM  
Jun-24-20 08:31AM  
Jun-23-20 04:01PM  
Jun-15-20 08:42AM  
Jun-11-20 12:00PM  
Jun-09-20 07:46AM  
06:12AM  
Jun-08-20 04:01PM  
09:49AM  
Jun-01-20 08:37AM  
May-12-20 04:01PM  
Apr-23-20 08:00AM  
Mar-30-20 09:41AM  
Mar-11-20 08:00AM  
Mar-04-20 04:05PM  
Jan-20-20 04:37AM  
Jan-07-20 10:21AM  
Jan-06-20 08:00AM  
Dec-23-19 07:52PM  
Nov-13-19 08:00AM  
Oct-25-19 04:30PM  
Oct-23-19 09:00AM  
07:54AM  
Oct-22-19 04:01PM  
Oct-02-19 08:00AM  
Oct-01-19 02:22PM  
Sep-24-19 08:00AM  
Sep-19-19 08:00AM  
Aug-07-19 04:05PM  
Jul-25-19 01:19PM  
08:00AM  
Jul-15-19 09:00AM  
Jul-11-19 11:14AM  
Jul-01-19 08:39AM  
Jun-12-19 08:00AM  
May-28-19 06:07AM  
May-24-19 08:49AM  
May-13-19 08:00AM  
May-06-19 04:13PM  
08:11AM  
Apr-29-19 08:00AM  
Apr-03-19 08:00AM  
Mar-27-19 08:46AM  
Mar-25-19 10:00AM  
08:00AM  
Mar-20-19 07:48AM  
Mar-18-19 08:30AM  
08:00AM  
Mar-15-19 04:05PM  
03:00PM  
07:39AM  
Mar-14-19 05:32PM  
Mar-11-19 04:05PM  
Dec-19-18 04:01PM  
Dec-12-18 06:47AM  
Nov-15-18 08:05AM  
08:00AM  
Oct-08-18 08:00AM  
Oct-01-18 08:00AM  
Sep-19-18 08:00AM  
Sep-17-18 08:00AM  
Sep-06-18 08:00AM  
Sep-04-18 08:00AM  
Aug-14-18 04:05PM  
Jul-30-18 08:00AM  
Jun-04-18 08:00AM  
May-16-18 08:00AM  
May-14-18 08:00AM  
Apr-03-18 06:15PM  
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harris William GDirectorOct 30Sale1.742,4974,34566,271Nov 03 06:55 PM
Sinclair AndrewDirectorJun 26Buy1.653,333,3305,499,99410,302,602Jul 06 04:03 PM
Abingworth LLP10% OwnerJun 26Buy1.653,333,3305,499,99410,302,602Jul 06 04:02 PM
SCHULER JACK W10% OwnerJun 26Buy1.657,575,75912,500,00211,368,862Jun 26 07:49 PM
SCHULER JACK W10% OwnerJun 10Buy1.97339,083666,8072,071,883Jun 12 08:32 PM
FEINBERG LARRY N10% OwnerJun 08Sale3.40150,918513,302655,000Jun 09 05:16 PM
FEINBERG LARRY N10% OwnerJun 05Sale3.3449,325164,578805,918Jun 09 05:16 PM